Do different lipid emulsions affect brain development? A single-center retrospective analysis

Samuele Caruggi1, Andrea Calandrino1, Benedetta Corradi2

  • 1Neonatal Intensive Care Unit, Department of Maternal and Neonatal Health, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Frontiers in Nutrition
|February 20, 2026
PubMed

Insights

This study found no significant differences in brain maturation or neurodevelopment at two years for very low birth weight infants receiving either SMOFlipid® or Intralipid® during parenteral nutrition.

Area of Science:

  • Neonatal Medicine
  • Neuroscience
  • Nutritional Science

Background:

  • Preterm birth poses risks to infant brain development due to extrauterine factors.
  • Parenteral nutrition lipid choices may impact neurodevelopmental outcomes.
  • SMOFlipid®, rich in omega-3 fatty acids, may reduce inflammation and bronchopulmonary dysplasia risk.

Purpose of the Study:

  • To compare brain maturation using MRI and neurodevelopment at two years in VLBW infants.
  • To evaluate the effect of SMOFlipid® versus Intralipid® in parenteral nutrition on preterm infant outcomes.

Main Methods:

  • Retrospective observational cohort study of 121 VLBW infants.
  • Infants received either multi-component lipid emulsion (MLE) or soybean lipid emulsion (SLE).
  • Brain maturation assessed by Total Maturation Score (TMS) on MRI; neurodevelopment assessed by Griffith's scales at 24 months corrected age.

Main Results:

  • No statistically significant differences in TMS between SLE and MLE groups.
  • Neurodevelopmental outcomes also showed no significant differences between the groups.
  • 121 VLBW infants were included, with 62 in the MLE group and 49 in the SLE group.

Conclusions:

  • This study did not identify an optimal lipid emulsion for preterm infants.
  • Further research is needed to determine the best lipid formulations for parenteral nutrition in VLBW infants.
Abstract